Turnstone Biologics Other Current Liabilities

Turnstone Biologics (TSBX) currently reports a other current liabilities of $3.2M as of June 2025. That compares with $12M in the prior-year period — down 73.7% year over year. Use the charts on this page to explore Turnstone Biologics's other current liabilities history and peer comparisons.

Turnstone Biologics's other current liabilities decreased from $12M to $3.2M — a 73.7% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Turnstone Biologics reported $3.2M in other current liabilities as of June 2025. That compares with $12M in the prior-year period — down 73.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Turnstone Biologics, and consider following TSBX for alerts when major investors trade the stock.